UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

Diabetes, obesity & metabolism, 2019-08, Vol.21 (8), p.1861-1870

2019

Volltextzugriff (PDF)

Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes

Arteriosclerosis, thrombosis, and vascular biology, 2021-02, Vol.41 (2), p.962-975

2021

Volltextzugriff (PDF)

Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects

Arteriosclerosis, thrombosis, and vascular biology, 2011-09, Vol.31 (9), p.2144-2150

2011

Volltextzugriff (PDF)

Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study

Arteriosclerosis, thrombosis, and vascular biology, 2015-10, Vol.35 (10), p.2218-2224

2015

Volltextzugriff (PDF)

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

Mediators of Inflammation, 2006-01, Vol.2006 (3), p.8-12

2006

Volltextzugriff (PDF)

Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects

Journal of clinical lipidology, 2020-01, Vol.14 (1), p.77-87

2020

Volltextzugriff (PDF)

Interrelationships Between the Kinetics of VLDL Subspecies and HDL Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study

The journal of clinical endocrinology and metabolism, 2014-11, Vol.99 (11), p.4281-4290

2014

Volltextzugriff (PDF)

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity

The journal of clinical endocrinology and metabolism, 2016-04, Vol.101 (4), p.1398-1406

2016

Volltextzugriff (PDF)

Association of Paraoxonase-1 Activity and Concentration With Angiographic Severity and Extent of Coronary Artery Disease

Journal of the American College of Cardiology, 2006-06, Vol.47 (12), p.2429-2435

2006

Volltextzugriff (PDF)

Association of Carotid Intima-Media Thickness With Angiographic Severity and Extent of Coronary Artery Disease

The American journal of cardiology, 2006-03, Vol.97 (5), p.624-629

2006

Volltextzugriff (PDF)

ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency

Arteriosclerosis, thrombosis, and vascular biology, 1995-09, Vol.15 (9), p.1294

1995

Volltextzugriff (PDF)

Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin

The Annals of pharmacotherapy, 2004-04, Vol.38 (4), p.719-719

2004

Volltextzugriff (PDF)

Reviewing statin therapy in diabetes—Towards the best practise

Primary care diabetes, 2010-04, Vol.4 (1), p.9-15

2010

Volltextzugriff (PDF)

Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease

Nutrition, metabolism, and cardiovascular diseases, 2008-05, Vol.18 (4), p.271-277

2008

Volltextzugriff (PDF)

Increase of Apolipoprotein A-V During Postprandial Lipemia Parallels the Response of Triglyceride-Rich Lipoproteins in Type 2 Diabetes: No relationship between apoA-V and postheparin plasma lipolytic activity

Diabetes care, 2007-08, Vol.30 (8), p.2083-2085

2007

Volltextzugriff (PDF)

Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity

Atherosclerosis, 1993-08, Vol.102 (1), p.79-89

1993

Volltextzugriff (PDF)

The Increase of Apolipoprotein A-V During Postprandial Lipemia Parallels the Response of Triglyceride-Rich Lipoproteins in Type 2 Diabetes

Diabetes care, 2007-08, Vol.30 (8), p.2083-2085

2007

Volltextzugriff (PDF)

Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease

Annals of medicine (Helsinki), 2007, Vol.39 (2), p.137-144

2007

Volltextzugriff (PDF)

Rhabdomyolysis in a patient receiving atorvastatin and fluconazole

European journal of clinical pharmacology, 2005-02, Vol.60 (12), p.905-907

2005

Volltextzugriff (PDF)

Cardiovascular disorders in dental practice

Den Norske tannlaegeforenings tidende, 2005, Vol.115 (2)

2005

Volltextzugriff (PDF)

Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein

Atherosclerosis, 1996-12, Vol.127 (2), p.245-253

1996

Volltextzugriff (PDF)

Regulation of apolipoprotein A-I-containing lipoproteins in IDDM

Diabetes (New York, N.Y.), 1993-09, Vol.42 (9), p.1281-1288

1993

Volltextzugriff (PDF)

HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus

Circulation (New York, N.Y.), 1995-08, Vol.92 (3), p.364-370

1995

Volltextzugriff (PDF)

Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects

Coronary artery disease, 2001-03, Vol.12 (2), p.99-106

2001

Volltextzugriff (PDF)

A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression

Journal of lipid research, 1996-04, Vol.37 (4), p.825-834

1996

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(31)
magazinearticle
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes

Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects

Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects

Interrelationships Between the Kinetics of VLDL Subspecies and HDL Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity

Association of Paraoxonase-1 Activity and Concentration With Angiographic Severity and Extent of Coronary Artery Disease

Association of Carotid Intima-Media Thickness With Angiographic Severity and Extent of Coronary Artery Disease

ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency

Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin

Reviewing statin therapy in diabetes—Towards the best practise

Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease

Increase of Apolipoprotein A-V During Postprandial Lipemia Parallels the Response of Triglyceride-Rich Lipoproteins in Type 2 Diabetes: No relationship between apoA-V and postheparin plasma lipolytic activity

Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity

The Increase of Apolipoprotein A-V During Postprandial Lipemia Parallels the Response of Triglyceride-Rich Lipoproteins in Type 2 Diabetes

Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease

Rhabdomyolysis in a patient receiving atorvastatin and fluconazole

Cardiovascular disorders in dental practice

Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein

Regulation of apolipoprotein A-I-containing lipoproteins in IDDM

HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus

Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects

A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression

Suchergebnisse filtern